Log In
Print this Print this

MVA-HPV-IL2 (TG4001) (formerly RG3484, RO5217790)

Also known as: formerly R3484

  Manage Alerts
Collapse Summary General Information
Company Transgene S.A.
DescriptionModified Vaccinia Ankara (MVA) virus vector encoding HPV types 16 E6 and E7 antigens and an IL-2 adjuvant
Molecular Target Interleukin-2 (IL-2)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today